Cardiovascular outcome trials of diabetes drugs: lessons learned

被引：9
|
作者：
Taylor, Simeon I. [1 ]
Leslie, Bruce R. [2 ]
机构：
[1] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA
[2] Seventh Doctor Consulting, Princeton, NJ USA
来源：
JOURNAL OF CLINICAL INVESTIGATION | 2018年 / 128卷 / 03期
关键词：
TYPE-2; EMPAGLIFLOZIN; LIRAGLUTIDE; EVENTS; DEATH;
D O I：
10.1172/JCI99820
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：893 / 896
页数：4
相关论文
共 50 条
  • [31] Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trials
    Hinnen, Deborah
    Kruger, Davida F.
    DIABETES METABOLIC SYNDROME AND OBESITY, 2019, 12 : 447 - 454
  • [32] Research digest: more cardiovascular outcome trials in diabetes
    Sattar, Naveed
    Preiss, David
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (09): : 687 - 687
  • [33] A review of cardiovascular outcome trials in type 2 diabetes
    Cypryk, Katarzyna
    Malecki, Piotr
    ENDOKRYNOLOGIA POLSKA, 2018, 69 (04) : 424 - 431
  • [34] Cardiovascular Outcome Trials of Diabetes and Obesity Drugs: Implications for Conditional Approval and Early Phase Clinical Development
    Krentz A.J.
    Rodriguez-Araujo G.
    Pharmaceutical Medicine, 2017, 31 (6) : 399 - 421
  • [35] CARDIOVASCULAR OUTCOME TRIALS-WHAT HAVE WE LEARNED FROM?
    Guja, Cristian
    INTERDIAB 2017: DIABETES MELLITUS IN INTERNAL MEDICINE, 2017, : 31 - 38
  • [36] Non-inferiority study design: lessons to be learned from cardiovascular trials
    Head, Stuart J.
    Kaul, Sanjay
    Bogers, Ad J. J. C.
    Kappetein, A. Pieter
    EUROPEAN HEART JOURNAL, 2012, 33 (11) : 1318 - 1324
  • [37] Drugs and diabetes: understanding the new breed of cardiovascular safety trials
    Adler, Amanda Ingham
    LANCET DIABETES & ENDOCRINOLOGY, 2013, 1 (03): : 175 - 177
  • [38] Cardiovascular outcome trials of glucose-lowering drugs in type 2 diabetes: 10 frequently asked questions
    George, Jyothis T.
    PRACTICAL DIABETES, 2015, 32 (08) : 301 - 304
  • [39] Glucose-lowering drugs and heart failure: implications of recent cardiovascular outcome trials in type 2 diabetes
    Cattadori, Gaia
    Pantanetti, Paola
    Ambrosio, Giuseppe
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 157
  • [40] Lessons learned from nine clinical trials of disease-modifying osteoarthritis drugs
    Brandt, KD
    Mazzuca, SA
    ARTHRITIS AND RHEUMATISM, 2005, 52 (11): : 3349 - 3359
12345